- Home
- PBA vs ALGN Comparison
PBA vs ALGN Comparison
Compare PBA & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBA
- ALGN
- Stock Information
- Founded
- PBA 1997
- ALGN 1997
- Country
- PBA Canada
- ALGN United States
- Employees
- PBA N/A
- ALGN N/A
- Industry
- PBA Oil & Gas Production
- ALGN Industrial Specialties
- Sector
- PBA Energy
- ALGN Health Care
- Exchange
- PBA Nasdaq
- ALGN Nasdaq
- Market Cap
- PBA 21.0B
- ALGN 17.4B
- IPO Year
- PBA N/A
- ALGN N/A
- Fundamental
- Price
- PBA $36.17
- ALGN $190.43
- Analyst Decision
- PBA Buy
- ALGN Buy
- Analyst Count
- PBA 1
- ALGN 11
- Target Price
- PBA $59.00
- ALGN $267.40
- AVG Volume (30 Days)
- PBA 1.7M
- ALGN 938.7K
- Earning Date
- PBA 02-27-2025
- ALGN 02-05-2025
- Dividend Yield
- PBA 5.53%
- ALGN N/A
- EPS Growth
- PBA 51.43
- ALGN N/A
- EPS
- PBA 2.43
- ALGN 5.62
- Revenue
- PBA $7,305,229,650.00
- ALGN $3,999,012,000.00
- Revenue This Year
- PBA N/A
- ALGN $8.05
- Revenue Next Year
- PBA $13.47
- ALGN $7.94
- P/E Ratio
- PBA $14.90
- ALGN $33.88
- Revenue Growth
- PBA 37.18
- ALGN 3.54
- 52 Week Low
- PBA $33.83
- ALGN $186.82
- 52 Week High
- PBA $43.44
- ALGN $335.40
- Technical
- Relative Strength Index (RSI)
- PBA 43.29
- ALGN 25.41
- Support Level
- PBA $35.85
- ALGN $210.53
- Resistance Level
- PBA $37.26
- ALGN $208.65
- Average True Range (ATR)
- PBA 0.61
- ALGN 7.51
- MACD
- PBA 0.03
- ALGN -2.30
- Stochastic Oscillator
- PBA 56.40
- ALGN 7.97
About PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its assets include pipelines and gas gathering as well as assets across fractionation, storage, and propane exports.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.